Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
NAGE
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
NAGE
Niagen Bioscience, Inc. Common Stock
52w low +5.2%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
claims
niagen
bioscience
annual
growth
million
national
advertising
division
reus
cata
supported
others
StonvexStonvexStonvexStonvex